Multifunctional receptor stabilin-1 in homeostasis and disease

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 2039-2053

  Kzhyshkowska, Julia ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

Cell adhesion; Chitinase like protein; Endocytosis; Endothelial cell; GGAs; Macrophage; Phagocytosis; Placental lactogen; Secretion; SI CLP; SPARC; Trans Golgi network; Transcytosis

Indexed keywords

ADAPTOR PROTEIN; CELL PROTEIN; CHITINASE; GROWTH HORMONE; PROLACTIN; SCAVENGER RECEPTOR; STABILIN 1; UNCLASSIFIED DRUG; HOMING RECEPTOR; NERVE CELL ADHESION MOLECULE; STAB1 PROTEIN, HUMAN;

ANGIOGENESIS; BLOOD VESSEL; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL SELECTION; CELL SURFACE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CYTOPLASM; ENDOCYTOSIS; ENDOTHELIUM CELL; HEALTH; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; LYSOSOME; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; PSORIASIS; SHORT SURVEY; TRANS GOLGI NETWORK; TRANSCYTOSIS; TUMOR GROWTH; TUMOR VASCULARIZATION; WOUND HEALING; ANIMAL; BIOLOGICAL MODEL; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALIA;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES, NEURONAL; HOMEOSTASIS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; RECEPTORS, LYMPHOCYTE HOMING; TRANS-GOLGI NETWORK;

EID: 78349290716     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.189     Document Type: Short Survey

References (86)

1. Goerdt, S., Walsh, L.J., Murphy, G.F., and Pober, J.S. (1991) Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J. Cell Biol. 113, 1425-1437.
2. Goerdt, S., Bhardwaj, R., and Sorg, C. (1993) Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am. J. Pathol. 142, 1409-1422. (Pubitemid 24058128)
3. Kodelja, V., Muller, C., Tenorio, S., Schebesch, C., Orfanos, C.E., and Goerdt, S. (1997) Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197, 478-493.
4. Politz, O., Gratchev, A., McCourt, P.A., Schledzewski, K., Guillot, P., Johansson, S., Svineng, G., Franke, P., Kannicht, C., Kzhyshkowska, J., Longati, P., Velten, F.W., Johansson, S., and Goerdt, S. (2002) Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem. J. 362, 155-164.
5. McCourt, P.A., Smedsrod, B.H., Melkko, J., and Johansson, S. (1999) Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology 30, 1276-1286. (Pubitemid 29510867)
6. Kzhyshkowska, J., Gratchev, A., Martens, J.H., Pervushina, O., Mamidi, S., Johansson, S., Schledzewski, K., Hansen, B., He, X., Tang, J., Nakayama, K., and Goerdt, S. (2004) Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors. J. Leukoc. Biol. 76, 1151-1161.
7. Tamura, Y., Adachi, H., Osuga, J., Ohashi, K., Yahagi, N., Sekiya, M., Okazaki, H., Tomita, S., Iizuka, Y., Shimano, H., Nagai, R., Kimura, S., Tsujimoto, M., and Ishibashi, S. (2003) FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J. Biol. Chem. 278, 12613-12617.
8. Adachi, H. and Tsujimoto, M. (2002) FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities. J. Biol. Chem. 277, 34264-34270.
9. Irjala, H., Elima, K., Johansson, E.L., Merinen, M., Kontula, K., Alanen, K., Grenman, R., Salmi, M., and Jalkanen, S. (2003) The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. Eur. J. Immunol. 33, 815-824.
10. Kzhyshkowska, J., Gratchev, A., and Goerdt, S. (2006) Stabilin-1, a homeostatic scavenger receptor with multiple functions. J. Cell. Mol. Med. 10, 635-649. (Pubitemid 44874274)
11. Prevo, R., Banerji, S., Ni, J., and Jackson, D.G. (2004) Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). J. Biol. Chem. 279, 52580-52592.
12. Hansen, B., Longati, P., Elvevold, K., Nedredal, G.I., Schledzewski, K., Olsen, R., Falkowski, M., Kzhyshkowska, J., Carlsson, F., Johansson, S., Smedsrod, B., Goerdt, S., Johansson, S., and McCourt, P. (2005) Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp. Cell Res. 303, 160-173.
13. Martens, J.H., Kzhyshkowska, J., Falkowski-Hansen, M., Schledzewski, K., Gratchev, A., Mansmann, U., Schmuttermaier, C., Dippel, E., Koenen, W., Riedel, F., Sankala, M., Tryggvason, K., Kobzik, L., Moldenhauer, G., Arnold, B., and Goerdt, S. (2006) Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J. Pathol. 208, 574-589.
14. Qian, H., Johansson, S., McCourt, P., Smedsrod, B., Ekblom, M., and Johansson, S. (2009) Stabilins are expressed in bone marrow sinusoidal endothelial cells and mediate scavenging and cell adhesive functions. Biochem. Biophys. Res. Commun. 390, 883-886.
15. Salmi, M., Koskinen, K., Henttinen, T., Elima, K., and Jalkanen, S. (2004) CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 104, 3849-3857. (Pubitemid 39620128)
16. Walsh, L.J., Goerdt, S., Pober, J.S., Sueki, H., and Murphy, G.F. (1991) MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab. Invest. 65, 732-741.
17. Irjala, H., Alanen, K., Grenman, R., Heikkila, P., Joensuu, H., and Jalkanen, S. (2003) Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res. 63, 4671-4676.
18. Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C.D., Dippel, E., Kodelja, V., and Orfanos, C.E. (1999) Alternative versus classical activation of macrophages. Pathobiology 67, 222-226. (Pubitemid 30135909)
19. Goerdt, S.and Orfanos, C.E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
20. Schledzewski, K., Falkowski, M., Moldenhauer, G., Metharom, P., Kzhyshkowska, J., Ganss, R., Demory, A., Falkowska-Hansen, B., Kurzen, H., Ugurel, S., Geginat, G., Arnold, B., and Goerdt, S. (2006) Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1(+), F4/80(+), CD11b(+) macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J. Pathol. 209, 67-77.
21. Schmieder, A., Schledzewski, K., Michel, J., Tuckermann, J.P., Tome, L., Sticht, C., Gkaniatsou, C., Nicolay, J.P., Demory, A., Faulhaber, J., Kzhyshkowska, J., Geraud, C., and Goerdt, S. (2010) Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. Int. J. Cancer. [Epub ahead of print]
22. Moos, V., Schmidt, C., Geelhaar, A., Kunkel, D., Allers, K., Schinnerling, K., Loddenkemper, C., Fenollar, F., Moter, A., Raoult, D., Ignatius, R., and Schneider, T. (2010) Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology 138, 210-220.
23. Mosig, S., Rennert, K., Krause, S., Kzhyshkowska, J., Neunubel, K., Heller, R., and Funke, H. (2009) Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J. 23, 866-874.
24. Soutar, A.K. and Naoumova, R.P. (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med. 4, 214-225.
25. Bonifacino, J.S. (2004) The GGA proteins: adaptors on the move. Nat. Rev. Mol. Cell Biol. 5, 23-32.
26. Zhang, J., Gratchev, A., Riabov, V., Mamidi, S., Schmuttermaier, C., Krusell, L., Kremmer, E., Workman, G., Sage, E.H., Jalkanen, S., Goerdt, S., and Kzhyshkowska, J. (2009) A novel GGA-binding site is required for intracellular sorting mediated by stabilin-1. Mol. Cell. Biol. 29, 6097-6105.
27. Ghosh, P., Dahms, N.M., and Kornfeld, S. (2003) Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 4, 202-212. (Pubitemid 36288042)
28. Adachi, H. and Tsujimoto, M. (2010) Adaptor protein sorting nexin 17 interacts with the scavenger receptor FEEL-1/stabilin-1 and modulates its expression on the cell surface. Biochim. Biophys. Acta 1803, 553-563.
29. Peiser, L., Mukhopadhyay, S., and Gordon, S. (2002) Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14, 123-128.
30. Gordon, S. (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111, 927-930.
31. Areschoug, T. and Gordon, S. (2009) Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell. Microbiol. 11, 1160-1169.
32. Greaves, D.R. and Gordon, S. (2005) Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46, 11-20.
33. Krieger, M. and Stern, D.M. (2001) Series introduction: multiligand receptors and human disease. J. Clin. Invest. 108, 645-647.
34. Kzhyshkowska, J. and Krusell, L. (2009) Cross-talk between endocytic clearance and secretion in macrophages. Immunobiology 214, 576-593.
35. Kzhyshkowska, J., Gratchev, A., Brundiers, H., Mamidi, S., Krusell, L., and Goerdt, S. (2005) Phosphatidylinositide 3-kinase activity is required for stabilin-1-mediated endosomal transport of acLDL. Immunobiology 210, 161-173.
36. Maxfield, F.R. and McGraw, T.E. (2004) Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5, 121-132.
37. Kzhyshkowska, J., Workman, G., Cardo-Vila, M., Arap, W., Pasqualini, R., Gratchev, A., Krusell, L., Goerdt, S., and Sage, E.H. (2006) Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J. Immunol. 176, 5825-5832.
38. Brekken, R.A. and Sage, E.H. (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19, 816-827.
39. Framson, P.E. and Sage, E.H. (2004) SPARC and tumor growth: where the seed meets the soil? J. Cell. Biochem. 92, 679-690.
40. Arnold, S.A. and Brekken, R.A. (2009) SPARC: a matricellular regulator of tumorigenesis. J. Cell Commun. Signal. 3, 255-273.
41. Hsiao, Y.H., Lien, H.C., Hwa, H.L., Kuo, W.H., Chang, K.J., and Hsieh, F.J. (2010) SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Breast J. 16, 305-308.
42. Kos, K. and Wilding, J.P. (2010) SPARC: a key player in the pathologies associated with obesity and diabetes. Nat. Rev. Endocrinol. 6, 225-235.
43. Bradshaw, A.D. and Sage, E.H. (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 107, 1049-1054.
44. Murphy-Ullrich, J.E. (2001) The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J. Clin. Invest. 107, 785-790.
45. Bradshaw, A.D. (2009) The role of SPARC in extracellular matrix assembly. J. Cell Commun. Signal. 3, 239-246.
46. Koblinski, J.E., Kaplan-Singer, B.R., VanOsdol, S.J., Wu, M., Engbring, J.A., Wang, S., Goldsmith, C.M., Piper, J.T., Vostal, J.G., Harms, J.F., Welch, D.R., and Kleinman, H.K. (2005) Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res. 65, 7370-7377. (Pubitemid 41161270)
47. Alvarez, M.J., Prada, F., Salvatierra, E., Bravo, A.I., Lutzky, V.P., Carbone, C., Pitossi, F.J., Chuluyan, H.E., and Podhajcer, O.L. (2005) Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res. 65, 5123-5132.
48. Gordon, S. and Martinez, F.O. (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604.
49. Kzhyshkowska, J., Gratchev, A., Schmuttermaier, C., Brundiers, H., Krusell, L., Mamidi, S., Zhang, J., Workman, G., Sage, E.H., Anderle, C., Sedlmayr, P., and Goerdt, S. (2008) Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J. Immunol. 180, 3028-3037.
50. Anthony, R.V., Fanning, M.D., Limesand, S.W., and Liang, R. (1998) Placental lactogen and growth hormone: regulation and action. In Endocrinology of Pregnancy. Bazer, F.W., Ed. Humana Press, Totawa, NJ. pp. 461-490.
51. Falkowski, M., Schledzewski, K., Hansen, B., and Goerdt, S. (2003) Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem. Cell Biol. 120, 361-369.
52. Zhou, B., McGary, C.T., Weigel, J.A., Saxena, A., and Weigel, P.H. (2003) Purification and molecular identification of the human hyaluronan receptor for endocytosis. Glycobiology 13, 339-349.
53. Harris, E.N., Baggenstoss, B.A., and Weigel, P.H. (2009) Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1191-G1199.
54. Harris, E.N. and Weigel, P.H. (2008) The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E. Glycobiology 18, 638-648.
55. Harris, E.N., Weigel, J.A., and Weigel, P.H. (2008) The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin. J. Biol. Chem. 283, 17341-17350.
56. Politz, O., Kodelja, V., Guillot, P., Orfanos, C.E., and Goerdt, S. (2000) Pseudoexons and regulatory elements in the genomic sequence of the beta-chemokine, alternative macrophage activation-associated CC-chemokine (AMAC)-1. Cytokine 12, 120-126.
57. Kzhyshkowska, J., Mamidi, S., Gratchev, A., Kremmer, E., Schmuttermaier, C., Krusell, L., Haus, G., Utikal, J., Schledzewski, K., Scholtze, J., and Goerdt, S. (2006) Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107, 3221-3228.
58. Hollak, C.E., van Weely, S., van Oers, M.H., and Aerts, J.M. (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 93, 1288-1292. (Pubitemid 24087186)
59. Renkema, G.H., Boot, R.G., Muijsers, A.O., Donker-Koopman, W.E., and Aerts, J.M. (1995) Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J. Biol. Chem. 270, 2198-2202.
60. Boven, L.A., van Meurs, M., Boot, R.G., Mehta, A., Boon, L., Aerts, J.M., and Laman, J.D. (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am. J. Clin. Pathol. 122, 359-369.
61. Boot, R.G., Renkema, G.H., Strijland, A., van Zonneveld, A.J., and Aerts, J.M. (1995) Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J. Biol. Chem. 270, 26252-26256.
62. Boot, R.G., Blommaart, E.F., Swart, E., Ghauharali-van der Vlugt, K., Bijl, N., Moe, C., Place, A., and Aerts, J.M. (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J. Biol. Chem. 276, 6770-6778.
63. Renkema, G.H., Boot, R.G., Au, F.L., Donker-Koopman, W.E., Strijland, A., Muijsers, A.O., Hrebicek, M., and Aerts, J.M. (1998) Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur. J. Biochem. 251, 504-509.
64. Zhu, Z., Zheng, T., Homer, R.J., Kim, Y.K., Chen, N.Y., Cohn, L., Hamid, Q., and Elias, J.A. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304, 1678-1682.
65. Hogdall, E.V., Johansen, J.S., Kjaer, S.K., Price, P.A., Christensen, L., Blaakaer, J., Bock, J.E., Glud, E., and Hogdall, C.K. (2003) High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol. Rep. 10, 1535-1538.
66. Cintin, C., Johansen, J.S., Christensen, I.J., Price, P.A., Sorensen, S., and Nielsen, H.J. (1999) Serum YKL-40 and colorectal cancer. Br. J. Cancer 79, 1494-1499.
67. Cintin, C., Johansen, J.S., Christensen, I.J., Price, P.A., Sorensen, S., and Nielsen, H.J. (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95, 267-274.
68. Jensen, B.V., Johansen, J.S., and Price, P.A. (2003) High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin. Cancer Res. 9, 4423-4434.
69. Dupont, J., Tanwar, M.K., Thaler, H.T., Fleisher, M., Kauff, N., Hensley, M.L., Sabbatini, P., Anderson, S., Aghajanian, C., Holland, E.C., and Spriggs, D.R. (2004) Early detection and prognosis of ovarian cancer using serum YKL-40. J. Clin. Oncol. 22, 3330-3339.
70. Tanwar, M.K., Gilbert, M.R., and Holland, E.C. (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 62, 4364-4368.
71. Steenbakkers, P.G., Baeten, D., Rovers, E., Veys, E.M., Rijnders, A.W., Meijerink, J., De Keyser, F., and Boots, A.M. (2003) Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies. J. Immunol. 170, 5719-5727.
72. Vind, I., Johansen, J.S., Price, P.A., and Munkholm, P. (2003) Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 38, 599-605.
73. Tran, A., Benzaken, S., Saint-Paul, M.C., Guzman-Granier, E., Hastier, P., Pradier, C., Barjoan, E.M., Demuth, N., Longo, F., and Rampal, P. (2000) Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur. J. Gastroenterol. Hepatol. 12, 989-993.
74. Saitou, Y., Shiraki, K., Yamanaka, Y., Yamaguchi, Y., Kawakita, T., Yamamoto, N., Sugimoto, K., Murata, K., and Nakano, T. (2005) Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J. Gastroenterol. 11, 476-481.
75. La Montagna, G., D'Angelo, S., and Valentini, G. (2003) Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease. J. Rheumatol. 30, 2147-2151.
76. Owhashi, M., Arita, H., and Hayai, N. (2000) Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein. J. Biol. Chem. 275, 1279-1286.
77. Recklies, A.D., White, C., and Ling, H. (2002) The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem. J. 365, 119-126.
78. Ling, H. and Recklies, A.D. (2004) The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem. J. 380, 651-659.
79. Nishikawa, K.C. and Millis, A.J. (2003) gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp. Cell Res. 287, 79-87.
80. Oba, Y., Chung, H.Y., Choi, S.J., and Roodman, G.D. (2003) Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor. J. Bone Miner. Res. 18, 1332-1341.
81. Areshkov, P.A. and Kavsan, V.M. (2010) Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells. Tsitol. Genet. 44, 3-9.
82. Renkema, G.H., Boot, R.G., Strijland, A., Donker-Koopman, W.E., van den Berg, M., Muijsers, A.O., and Aerts, J.M. (1997) Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur. J. Biochem. 244, 279-285.
83. Park, S.Y., Jung, M.Y., Lee, S.J., Kang, K.B., Gratchev, A., Riabov, V., Kzhyshkowska, J., and Kim, I.S. (2009) Stabilin-1 mediates phosphatidylserine- dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 122, 3365-3373.
84. Park, S.Y., Jung, M.Y., Kim, H.J., Lee, S.J., Kim, S.Y., Lee, B.H., Kwon, T.H., Park, R.W., and Kim, I.S. (2008) Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15, 192-201.
85. Karikoski, M., Irjala, H., Maksimow, M., Miiluniemi, M., Granfors, K., Hernesniemi, S., Elima, K., Moldenhauer, G., Schledzewski, K., Kzhyshkowska, J., Goerdt, S., Salmi, M., and Jalkanen, S. (2009) Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation. Eur. J. Immunol. 39, 3477-3487.
86. Kzhyshkowska, J., Marciniak-Czochra, A., and Gratchev, A. (2008) Perspectives of mathematical modelling for understanding of intracellular signalling and vesicular trafficking in macrophages. Immunobiology 212, 813-825.